{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:02:28Z","timestamp":1763766148661},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24 DK080941","U01 CA152926","U01 CA182940","U54 CA163059"],"award-info":[{"award-number":["K24 DK080941","U01 CA152926","U01 CA182940","U54 CA163059"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bpgastro.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.bpg.2014.12.002","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T23:51:01Z","timestamp":1419033061000},"page":"51-63","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cost considerations in implementing a screening and surveillance strategy for Barrett's oesophagus"],"prefix":"10.1016","volume":"29","author":[{"given":"John M.","family":"Inadomi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.bpg.2014.12.002_bib1","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.1996.03540160061034","article-title":"Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine","volume":"276","author":"Siegel","year":"1996","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.bpg.2014.12.002_bib2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jama.1996.03540140060028","article-title":"The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine","volume":"276","author":"Russell","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.bpg.2014.12.002_bib3","series-title":"Cost-effectiveness in health and medicine","author":"Gold","year":"1996"},{"key":"10.1016\/j.bpg.2014.12.002_bib4","series-title":"Meta-analysis, decision analysis, and cost-effectiveness analysis : methods for quantitative synthesis in medicine","author":"Petitti","year":"2000"},{"issue":"15","key":"10.1016\/j.bpg.2014.12.002_bib5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.1996.03540150055031","article-title":"Recommendations of the panel on cost-effectiveness in health and medicine","volume":"276","author":"Weinstein","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.bpg.2014.12.002_bib6","series-title":"Barrett's esophagus and esophageal adenocarcinoma","author":"Sharma","year":"2006"},{"issue":"3","key":"10.1016\/j.bpg.2014.12.002_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1067\/mge.2003.101","article-title":"Cost-effectiveness of screening a population with chronic gastroesophageal reflux","volume":"57","author":"Nietert","year":"2003","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"10.1016\/j.bpg.2014.12.002_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-138-3-200302040-00009","article-title":"Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis","volume":"138","author":"Inadomi","year":"2003","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.bpg.2014.12.002_bib9","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1542-3565(04)00394-5","article-title":"Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease","volume":"2","author":"Gerson","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.bpg.2014.12.002_bib10","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1572-0241.2000.02173.x","article-title":"Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective?","volume":"95","author":"Soni","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.bpg.2014.12.002_bib11","first-page":"670","article-title":"A\u00a0guide for surveillance of patients with Barrett's esophagus","volume":"89","author":"Provenzale","year":"1994","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.bpg.2014.12.002_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1052-5157(18)30330-1","article-title":"Economic aspects of endoscopic screening for intestinal precancerous conditions","volume":"7","author":"Sonnenberg","year":"1997","journal-title":"Gastrointest Endosc Clin N Am"},{"issue":"6","key":"10.1016\/j.bpg.2014.12.002_bib13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1572-0241.1998.00275.x","article-title":"Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer","volume":"93","author":"Streitz","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.bpg.2014.12.002_bib14","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/j.1572-0241.1999.01276.x","article-title":"Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk","volume":"94","author":"Provenzale","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.bpg.2014.12.002_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2036.2002.01146.x","article-title":"Medical decision analysis of endoscopic surveillance of Barrett's oesophagus to prevent oesophageal adenocarcinoma","volume":"16","author":"Sonnenberg","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.bpg.2014.12.002_bib16","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1023\/A:1024146823549","article-title":"Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia","volume":"48","author":"Hur","year":"2003","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.bpg.2014.12.002_bib17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0016-5107(04)02167-4","article-title":"Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus","volume":"60","author":"Vij","year":"2004","journal-title":"Gastrointest Endosc"},{"issue":"12","key":"10.1016\/j.bpg.2014.12.002_bib18","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1136\/gut.2003.033837","article-title":"What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis","volume":"53","author":"Shaheen","year":"2004","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.bpg.2014.12.002_bib19","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0016-5085(03)00393-7","article-title":"Medical decision analysis of chemoprevention against esophageal adenocarcinoma","volume":"124","author":"Sonnenberg","year":"2003","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bpg.2014.12.002_bib20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jnci\/djh039","article-title":"Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus","volume":"96","author":"Hur","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.bpg.2014.12.002_bib21","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1053\/j.gastro.2011.01.031","article-title":"American Gastroenterological Association medical position statement on the management of Barrett's esophagus","volume":"140","author":"Spechler","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bpg.2014.12.002_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1440-1746.2010.06506.x","article-title":"Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations","volume":"26","author":"Hirst","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.bpg.2014.12.002_bib23","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1053\/j.gastro.2009.02.062","article-title":"A\u00a0cost-utility analysis of ablative therapy for Barrett's esophagus","volume":"136","author":"Inadomi","year":"2009","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bpg.2014.12.002_bib24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1053\/j.gastro.2012.05.010","article-title":"The cost effectiveness of radiofrequency ablation for Barrett's esophagus","volume":"143","author":"Hur","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bpg.2014.12.002_bib25","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2011.04.061","article-title":"Durability of radiofrequency ablation in Barrett's esophagus with dysplasia","volume":"141","author":"Shaheen","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bpg.2014.12.002_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/aje\/kwn121","article-title":"The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis","volume":"168","author":"Yousef","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.bpg.2014.12.002_bib27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1442-2050.2008.00857.x","article-title":"Critical reappraisal of current surveillance strategies for Barrett's esophagus: analysis of a large German Barrett's database","volume":"21","author":"von Rahden","year":"2008","journal-title":"Dis Esophagus"},{"issue":"4","key":"10.1016\/j.bpg.2014.12.002_bib28","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/j.gastro.2011.06.055","article-title":"Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus","volume":"141","author":"Wani","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2014.12.002_bib29","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cgh.2006.03.001","article-title":"Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus","volume":"4","author":"Sharma","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.bpg.2014.12.002_bib30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0046-8177(88)80344-7","article-title":"Observer variation in the diagnosis of dysplasia in Barrett's esophagus","volume":"19","author":"Reid","year":"1988","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.bpg.2014.12.002_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0016-5107(99)70339-1","article-title":"Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice","volume":"50","author":"Alikhan","year":"1999","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.bpg.2014.12.002_bib32","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/hupa.2001.23510","article-title":"Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation","volume":"32","author":"Montgomery","year":"2001","journal-title":"Hum Pathol"},{"issue":"1 Pt 2","key":"10.1016\/j.bpg.2014.12.002_bib33","first-page":"D31","article-title":"Reproducibility of histological criteria of dysplasia in Barrett mucosa","volume":"18","author":"Sagan","year":"1994","journal-title":"Gastroenterol Clin Biol"},{"issue":"3","key":"10.1016\/j.bpg.2014.12.002_bib34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1158\/1940-6207.CAPR-13-0191-T","article-title":"Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis","volume":"7","author":"Choi","year":"2014","journal-title":"Cancer Prev Res \u2013 Phila"},{"issue":"1","key":"10.1016\/j.bpg.2014.12.002_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2013-305372","article-title":"British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus","volume":"63","author":"Fitzgerald","year":"2014","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.bpg.2014.12.002_bib36","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199903183401101","article-title":"Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma","volume":"340","author":"Lagergren","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.bpg.2014.12.002_bib37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/gast.2002.34748","article-title":"Prevalence of Barrett's esophagus in asymptomatic individuals","volume":"123","author":"Gerson","year":"2002","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1016\/j.bpg.2014.12.002_bib38","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","article-title":"Incidence of adenocarcinoma among patients with Barrett's esophagus","volume":"365","author":"Hvid-Jensen","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.bpg.2014.12.002_bib39","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1053\/gast.2001.25065","article-title":"Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia","volume":"120","author":"Schnell","year":"2001","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bpg.2014.12.002_bib40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/gast.2000.9302","article-title":"Is there publication bias in the reporting of cancer risk in Barrett's esophagus?","volume":"119","author":"Shaheen","year":"2000","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bpg.2014.12.002_bib41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cgh.2009.10.010","article-title":"Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis","volume":"8","author":"Sikkema","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.bpg.2014.12.002_bib42","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5009\/gnl.2014.8.4.356","article-title":"Barrett's esophagus and Cancer risk: how research advances can impact clinical practice","volume":"8","author":"di Pietro","year":"2014","journal-title":"Gut Liver"},{"issue":"22","key":"10.1016\/j.bpg.2014.12.002_bib43","first-page":"8284","article-title":"p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium","volume":"61","author":"Wong","year":"2001","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.bpg.2014.12.002_bib44","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.4161\/epi.6.12.18199","article-title":"DNA methylation profiling in Barrett's esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses","volume":"6","author":"Kaz","year":"2011","journal-title":"Epigenetics"},{"issue":"10","key":"10.1016\/j.bpg.2014.12.002_bib45","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1158\/0008-5472.CAN-09-0028","article-title":"A\u00a0multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus","volume":"69","author":"Jin","year":"2009","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.bpg.2014.12.002_bib46","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1158\/1078-0432.CCR-12-2880","article-title":"DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus","volume":"19","author":"Alvi","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.bpg.2014.12.002_bib47","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.2591","article-title":"Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity","volume":"45","author":"Dulak","year":"2013","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.bpg.2014.12.002_bib48","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1111\/j.1572-0241.2001.05261.x","article-title":"Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables","volume":"96","author":"Rabinovitch","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.bpg.2014.12.002_bib49","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1111\/j.1572-0241.2001.04236.x","article-title":"Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression","volume":"96","author":"Reid","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.bpg.2014.12.002_bib50","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2217\/bmm.11.40","article-title":"Developing a nonendoscopic screening test for Barrett's esophagus","volume":"5","author":"Kadri","year":"2011","journal-title":"Biomark Med"},{"issue":"1","key":"10.1016\/j.bpg.2014.12.002_bib51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.gastro.2012.09.060","article-title":"Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus","volume":"144","author":"Benaglia","year":"2013","journal-title":"Gastroenterology"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691814001929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691814001929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T16:46:31Z","timestamp":1566146791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691814001929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1521691814001929"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2014.12.002","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost considerations in implementing a screening and surveillance strategy for Barrett's oesophagus","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2014.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}